Macular Degeneration Trial, Recruiting NCT05913063 Sponsor: Centre for Eye and Vision Research Condition: Macular Degeneration
Back to Macular Degeneration

Macular Degeneration Trial, Recruiting

NCT05913063
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed by a doctor with a disease affecting the macula (a part of the eye responsible for central vision)
  • People who have been diagnosed by a doctor with glaucoma (a condition that damages the optic nerve)
  • Older adults with normal vision who are the same age (born in the same year) as participants with a diagnosed eye condition

Who may not be able to join:

  • People who have any other eye condition or diagnosis beyond the one being studied

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benjamin Thompson, PhD, Centre for Eye and Vision Research

Phone: +852-3169-9631

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre for Eye and Vision Research
Registry
ClinicalTrials.gov
Start date
26 June 2023
Est. completion
1 July 2029

Where this trial is recruiting

Hong Kong

Primary endpoints

Perception of the structured light; Radius of the radial retinal polarizer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov